Sumaya Abuloha
Irbid, IR, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Do U.S. cancer drug sales reflect clinical benefit? Evidence from solid tumor drugs from 2008 to 2022.
Journal: Journal of cancer policy
Published: December 02, 2025
Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy.
Journal: Clinical drug investigation
Published: November 21, 2025
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022.
Journal: Health affairs scholar
Published: February 07, 2025
Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year period.
Journal: Journal of managed care & specialty pharmacy
Published: November 29, 2024
Long-term health benefit and economic return of time in range (TIR) improvement in individuals with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: September 11, 2024
A Review of the Cost-Effectiveness Evidence for FDA-Approved Cell and Gene Therapies.
Journal: Human gene therapy
Published: March 25, 2024
Racial/Ethnic Disparities in Use of Angiotensin II Receptor Type 2/4 Stimulatory Vs. Inhibitory Antihypertensive Among Hypertensive Adults in the USA.
Journal: Journal of racial and ethnic health disparities
Published: December 14, 2023
Complementary and alternative medicine for urinary tract illnesses: A cross-sectional survey in Jordan.
Journal: Complementary therapies in clinical practice
Published: August 19, 2020
Promotion of appropriate knowledge and attitude towards medicines among schoolchildren in Jordan: the role of teachers.
Journal: The International journal of pharmacy practice
Published: February 08, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026